Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Genetic defects in common variable immunodeficiency

Kopecký O, Lukesová S

. 2007 ; 34 (4) : 225-229.

Jazyk angličtina Země Velká Británie

Typ dokumentu přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc10000994

Common variable immunodeficiency (CVID) is the most frequent clinically manifested primary immunodeficiency. According to clinical and laboratory findings, CVID is a heterogeneous group of diseases. Recently, the defects of molecules regulating activation and terminal differentiation of B lymphocytes have been described in some patients with CVID. In this study, we show the overview of deficiencies of inducible costimulator, transmembrane activator and calcium-modulator and cytophilin ligand interactor, CD19 molecules, their genetic basis, pathogenesis and clinical manifestations.

Citace poskytuje Crossref.org

000      
00000naa 2200000 a 4500
001      
bmc10000994
003      
CZ-PrNML
005      
20111210154840.0
008      
100116s2007 xxk e eng||
009      
AR
024    __
$a 10.1111/j.1744-313x.2007.00681.x $2 doi
035    __
$a (PubMed)17627754
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Kopecký, Otakar, $d 1955- $7 jn20000401408
245    10
$a Genetic defects in common variable immunodeficiency / $c Kopecký O, Lukesová S
314    __
$a Second Department of Internal Medicine, Charles University in Prague, Faculty of Medicine, University Hospital, 500 05 Hradec Králové, Czech Republic. kopecky.otakar@fhnk.cz
520    9_
$a Common variable immunodeficiency (CVID) is the most frequent clinically manifested primary immunodeficiency. According to clinical and laboratory findings, CVID is a heterogeneous group of diseases. Recently, the defects of molecules regulating activation and terminal differentiation of B lymphocytes have been described in some patients with CVID. In this study, we show the overview of deficiencies of inducible costimulator, transmembrane activator and calcium-modulator and cytophilin ligand interactor, CD19 molecules, their genetic basis, pathogenesis and clinical manifestations.
650    _2
$a financování organizované $7 D005381
650    _2
$a zvířata $7 D000818
650    _2
$a běžná variabilní imunodeficience $x genetika $x imunologie $x patologie $7 D017074
650    _2
$a lidé $7 D006801
655    _2
$a přehledy $7 D016454
700    1_
$a Lukešová, Šárka $7 xx0078669
773    0_
$w MED00008484 $t International journal of immunogenetics $g Roč. 34, č. 4 (2007), s. 225-229 $x 1744-3121
910    __
$a ABA008 $b x $y 8
990    __
$a 20100114083259 $b ABA008
991    __
$a 20100117160105 $b ABA008
999    __
$a ok $b bmc $g 703722 $s 566164
BAS    __
$a 3
BMC    __
$a 2007 $b 34 $c 4 $d 225-229 $i 1744-3121 $m International journal of immunogenetics $x MED00008484
LZP    __
$a 2010-b1/vtme

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...